The difference in the overall survival between BRCA1/2-OC women with BC (median: not reached; mean: 16.4 years) and BRCA1/2-OC women without BC (median: 8.0 years; mean: 9.9 years) was also not statistically significant (p = 0.107). The gene discussed is BRCA1; the disease is breast cancer.